Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Seong HL, Meng OL, Irish AB; FAVOURED study team.

Nephrology (Carlton). 2015 Jul 24. doi: 10.1111/nep.12573. [Epub ahead of print]

PMID:
26205903
2.

Vitamin D therapy in chronic kidney disease: back to the future?

Damasiewicz MJ, Kerr PG, Polkinghorne KR.

Clin Nephrol. 2015 Aug;84(8):65-74. doi: 10.5414/CN108519.

PMID:
26152127
3.

The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.

Viecelli AK, Pascoe E, Polkinghorne KR, Hawley C, Paul-Brent PA, Badve SV, Cass A, Heritier S, Kerr PG, Mori TA, Robertson A, Seong HL, Irish AB; FAVOURED study team.

BMC Nephrol. 2015 Jun 27;16:89. doi: 10.1186/s12882-015-0089-2.

4.

An Incident Cohort Study Comparing Survival on Home Hemodialysis and Peritoneal Dialysis (Australia and New Zealand Dialysis and Transplantation Registry).

Nadeau-Fredette AC, Hawley CM, Pascoe EM, Chan CT, Clayton PA, Polkinghorne KR, Boudville N, Leblanc M, Johnson DW.

Clin J Am Soc Nephrol. 2015 Jun 11. pii: CJN.00840115. [Epub ahead of print]

PMID:
26068181
5.

Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study.

Nadeau-Fredette AC, Chan CT, Cho Y, Hawley CM, Pascoe EM, Clayton PA, Polkinghorne KR, Boudville N, Leblanc M, Johnson DW.

Nephrol Dial Transplant. 2015 Jun 4. pii: gfv132. [Epub ahead of print]

PMID:
26044832
6.

Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis Population.

Marshall MR, Polkinghorne KR, Kerr PG, Agar JW, Hawley CM, McDonald SP.

Am J Kidney Dis. 2015 May 6. pii: S0272-6386(15)00542-9. doi: 10.1053/j.ajkd.2015.03.014. [Epub ahead of print]

PMID:
25958081
7.

Research Priorities in CKD: Report of a National Workshop Conducted in Australia.

Tong A, Crowe S, Chando S, Cass A, Chadban SJ, Chapman JR, Gallagher M, Hawley CM, Hill S, Howard K, Johnson DW, Kerr PG, McKenzie A, Parker D, Perkovic V, Polkinghorne KR, Pollock C, Strippoli GF, Tugwell P, Walker RG, Webster AC, Wong G, Craig JC.

Am J Kidney Dis. 2015 Aug;66(2):212-22. doi: 10.1053/j.ajkd.2015.02.341. Epub 2015 May 2.

PMID:
25943716
8.

The association between body mass index and mortality in incident dialysis patients.

Badve SV, Paul SK, Klein K, Clayton PA, Hawley CM, Brown FG, Boudville N, Polkinghorne KR, McDonald SP, Johnson DW.

PLoS One. 2014 Dec 16;9(12):e114897. doi: 10.1371/journal.pone.0114897. eCollection 2014.

9.

Debate: Should dialysis at home be mandatory for all suitable ESRD patients?: home-based dialysis therapies are the second choice after transplantation.

Lewicki MC, Polkinghorne KR, Kerr PG.

Semin Dial. 2015 Mar-Apr;28(2):147-54. doi: 10.1111/sdi.12322. Epub 2014 Dec 7.

PMID:
25481976
10.
11.

Survival on home dialysis in New Zealand.

Marshall MR, Walker RC, Polkinghorne KR, Lynn KL.

PLoS One. 2014 May 7;9(5):e96847. doi: 10.1371/journal.pone.0096847. eCollection 2014.

12.

Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease.

Lo C, Lui M, Ranasinha S, Teede HJ, Kerr PG, Polkinghorne KR, Nathan DM, Zheng H, Zoungas S.

Diabetes Res Clin Pract. 2014 Apr;104(1):84-91. doi: 10.1016/j.diabres.2014.01.020. Epub 2014 Feb 3.

PMID:
24573088
13.

Arteriovenous fistula patency: some answers but questions remain.

Polkinghorne KR.

Am J Kidney Dis. 2014 Mar;63(3):384-6. doi: 10.1053/j.ajkd.2013.11.021. No abstract available.

PMID:
24560156
14.

Predictors and outcomes of transfers from peritoneal dialysis to hemodialysis.

Lan PG, Clayton PA, Saunders J, Polkinghorne KR, Snelling PL.

Perit Dial Int. 2015 May-Jun;35(3):306-15. doi: 10.3747/pdi.2013.00030. Epub 2014 Feb 4.

PMID:
24497591
15.

Elderly patients with CKD--dilemmas in dialysis therapy and vascular access.

Vachharajani TJ, Moist LM, Glickman MH, Vazquez MA, Polkinghorne KR, Lok CE, Lee TC.

Nat Rev Nephrol. 2014 Feb;10(2):116-22. doi: 10.1038/nrneph.2013.256. Epub 2013 Dec 3. Review.

PMID:
24296629
16.

Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis.

Ford SL, Polkinghorne KR, Longano A, Dowling J, Dayan S, Kerr PG, Holdsworth SR, Kitching AR, Summers SA.

Am J Kidney Dis. 2014 Feb;63(2):227-35. doi: 10.1053/j.ajkd.2013.08.025. Epub 2013 Oct 30.

PMID:
24183110
17.

Vancomycin-resistant enterococci colonization does not increase mortality in end-stage kidney failure: a case-control study.

Garner SE, Polkinghorne KR, Kotsanas D, Kerr PG, Korman TM, Stuart RL.

J Hosp Infect. 2013 Dec;85(4):289-96. doi: 10.1016/j.jhin.2013.09.005. Epub 2013 Sep 21.

PMID:
24161798
18.

Cystatin C versus creatinine in determining risk based on kidney function.

Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium.

N Engl J Med. 2013 Sep 5;369(10):932-43. doi: 10.1056/NEJMoa1214234.

19.

KHA-CARI Guideline: vascular access - central venous catheters, arteriovenous fistulae and arteriovenous grafts.

Polkinghorne KR, Chin GK, MacGinley RJ, Owen AR, Russell C, Talaulikar GS, Vale E, Lopez-Vargas PA.

Nephrology (Carlton). 2013 Nov;18(11):701-5. doi: 10.1111/nep.12132. No abstract available. Erratum in: Nephrology (Carlton). 2014 Jan;19(1):64.

PMID:
23855977
20.

Vascular access surveillance: time to end the controversy.

Polkinghorne KR.

Semin Dial. 2013 May-Jun;26(3):257-9. doi: 10.1111/sdi.12096. No abstract available.

PMID:
23679121
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk